 | • レポートコード：MRC2-11QY07550 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は医療用セボフルランのグローバル市場について調査・分析したレポートです。種類別（ジェネリック医薬品、オリジナル医薬品）市場規模、用途別（子供、大人）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別医療用セボフルランの競争状況、市場シェア ・世界の医療用セボフルラン市場：種類別市場規模 2015年-2020年（ジェネリック医薬品、オリジナル医薬品） ・世界の医療用セボフルラン市場：種類別市場規模予測 2021年-2026年（ジェネリック医薬品、オリジナル医薬品） ・世界の医療用セボフルラン市場：用途別市場規模 2015年-2020年（子供、大人） ・世界の医療用セボフルラン市場：用途別市場規模予測 2021年-2026年（子供、大人） ・北米の医療用セボフルラン市場分析：米国、カナダ ・ヨーロッパの医療用セボフルラン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの医療用セボフルラン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の医療用セボフルラン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの医療用セボフルラン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、Maruishi Pharmaceutical、Collins Ltd.、Mylan Seiyaku Ltd.、Shenzhen Mindray Bio-Medical Electronics Co., Ltd.、Baxter、BOC Healthcare、Abbvie、Piramal、Hengrui、Lunan、Hikma ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Medical Sevoflurane Market
The global Medical Sevoflurane market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Medical Sevoflurane Scope and Market Size
Medical Sevoflurane market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Medical Sevoflurane market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Medical Sevoflurane market is segmented into
Generic Drug
Original Drug
Segment by Application, the Medical Sevoflurane market is segmented into
Children
Adults
Regional and Country-level Analysis
The Medical Sevoflurane market is analysed and market size information is provided by regions (countries).
The key regions covered in the Medical Sevoflurane market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Medical Sevoflurane Market Share Analysis
Medical Sevoflurane market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Medical Sevoflurane business, the date to enter into the Medical Sevoflurane market, Medical Sevoflurane product introduction, recent developments, etc.
The major vendors covered:
Abbott Laboratories
Maruishi Pharmaceutical
Collins Ltd.
Mylan Seiyaku Ltd.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Baxter
BOC Healthcare
Abbvie
Piramal
Hengrui
Lunan
Hikma
1 Study Coverage
1.1 Medical Sevoflurane Product Introduction
1.2 Market Segments
1.3 Key Medical Sevoflurane Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Medical Sevoflurane Market Size Growth Rate by Type
1.4.2 Generic Drug
1.4.3 Original Drug
1.5 Market by Application
1.5.1 Global Medical Sevoflurane Market Size Growth Rate by Application
1.5.2 Children
1.5.3 Adults
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Medical Sevoflurane Market Size, Estimates and Forecasts
2.1.1 Global Medical Sevoflurane Revenue 2015-2026
2.1.2 Global Medical Sevoflurane Sales 2015-2026
2.2 Global Medical Sevoflurane, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Medical Sevoflurane Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Medical Sevoflurane Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Medical Sevoflurane Competitor Landscape by Players
3.1 Medical Sevoflurane Sales by Manufacturers
3.1.1 Medical Sevoflurane Sales by Manufacturers (2015-2020)
3.1.2 Medical Sevoflurane Sales Market Share by Manufacturers (2015-2020)
3.2 Medical Sevoflurane Revenue by Manufacturers
3.2.1 Medical Sevoflurane Revenue by Manufacturers (2015-2020)
3.2.2 Medical Sevoflurane Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Medical Sevoflurane Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Medical Sevoflurane Revenue in 2019
3.2.5 Global Medical Sevoflurane Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Medical Sevoflurane Price by Manufacturers
3.4 Medical Sevoflurane Manufacturing Base Distribution, Product Types
3.4.1 Medical Sevoflurane Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Medical Sevoflurane Product Type
3.4.3 Date of International Manufacturers Enter into Medical Sevoflurane Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Medical Sevoflurane Market Size by Type (2015-2020)
4.1.1 Global Medical Sevoflurane Sales by Type (2015-2020)
4.1.2 Global Medical Sevoflurane Revenue by Type (2015-2020)
4.1.3 Medical Sevoflurane Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Medical Sevoflurane Market Size Forecast by Type (2021-2026)
4.2.1 Global Medical Sevoflurane Sales Forecast by Type (2021-2026)
4.2.2 Global Medical Sevoflurane Revenue Forecast by Type (2021-2026)
4.2.3 Medical Sevoflurane Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Medical Sevoflurane Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Medical Sevoflurane Market Size by Application (2015-2020)
5.1.1 Global Medical Sevoflurane Sales by Application (2015-2020)
5.1.2 Global Medical Sevoflurane Revenue by Application (2015-2020)
5.1.3 Medical Sevoflurane Price by Application (2015-2020)
5.2 Medical Sevoflurane Market Size Forecast by Application (2021-2026)
5.2.1 Global Medical Sevoflurane Sales Forecast by Application (2021-2026)
5.2.2 Global Medical Sevoflurane Revenue Forecast by Application (2021-2026)
5.2.3 Global Medical Sevoflurane Price Forecast by Application (2021-2026)
6 North America
6.1 North America Medical Sevoflurane by Country
6.1.1 North America Medical Sevoflurane Sales by Country
6.1.2 North America Medical Sevoflurane Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Medical Sevoflurane Market Facts & Figures by Type
6.3 North America Medical Sevoflurane Market Facts & Figures by Application
7 Europe
7.1 Europe Medical Sevoflurane by Country
7.1.1 Europe Medical Sevoflurane Sales by Country
7.1.2 Europe Medical Sevoflurane Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Medical Sevoflurane Market Facts & Figures by Type
7.3 Europe Medical Sevoflurane Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Medical Sevoflurane by Region
8.1.1 Asia Pacific Medical Sevoflurane Sales by Region
8.1.2 Asia Pacific Medical Sevoflurane Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Medical Sevoflurane Market Facts & Figures by Type
8.3 Asia Pacific Medical Sevoflurane Market Facts & Figures by Application
9 Latin America
9.1 Latin America Medical Sevoflurane by Country
9.1.1 Latin America Medical Sevoflurane Sales by Country
9.1.2 Latin America Medical Sevoflurane Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Medical Sevoflurane Market Facts & Figures by Type
9.3 Central & South America Medical Sevoflurane Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Medical Sevoflurane by Country
10.1.1 Middle East and Africa Medical Sevoflurane Sales by Country
10.1.2 Middle East and Africa Medical Sevoflurane Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Medical Sevoflurane Market Facts & Figures by Type
10.3 Middle East and Africa Medical Sevoflurane Market Facts & Figures by Application
11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Corporation Information
11.1.2 Abbott Laboratories Description and Business Overview
11.1.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abbott Laboratories Medical Sevoflurane Products Offered
11.1.5 Abbott Laboratories Related Developments
11.2 Maruishi Pharmaceutical
11.2.1 Maruishi Pharmaceutical Corporation Information
11.2.2 Maruishi Pharmaceutical Description and Business Overview
11.2.3 Maruishi Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Maruishi Pharmaceutical Medical Sevoflurane Products Offered
11.2.5 Maruishi Pharmaceutical Related Developments
11.3 Collins Ltd.
11.3.1 Collins Ltd. Corporation Information
11.3.2 Collins Ltd. Description and Business Overview
11.3.3 Collins Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Collins Ltd. Medical Sevoflurane Products Offered
11.3.5 Collins Ltd. Related Developments
11.4 Mylan Seiyaku Ltd.
11.4.1 Mylan Seiyaku Ltd. Corporation Information
11.4.2 Mylan Seiyaku Ltd. Description and Business Overview
11.4.3 Mylan Seiyaku Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Mylan Seiyaku Ltd. Medical Sevoflurane Products Offered
11.4.5 Mylan Seiyaku Ltd. Related Developments
11.5 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
11.5.1 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Corporation Information
11.5.2 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Description and Business Overview
11.5.3 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Medical Sevoflurane Products Offered
11.5.5 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Related Developments
11.6 Baxter
11.6.1 Baxter Corporation Information
11.6.2 Baxter Description and Business Overview
11.6.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Baxter Medical Sevoflurane Products Offered
11.6.5 Baxter Related Developments
11.7 BOC Healthcare
11.7.1 BOC Healthcare Corporation Information
11.7.2 BOC Healthcare Description and Business Overview
11.7.3 BOC Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.7.4 BOC Healthcare Medical Sevoflurane Products Offered
11.7.5 BOC Healthcare Related Developments
11.8 Abbvie
11.8.1 Abbvie Corporation Information
11.8.2 Abbvie Description and Business Overview
11.8.3 Abbvie Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Abbvie Medical Sevoflurane Products Offered
11.8.5 Abbvie Related Developments
11.9 Piramal
11.9.1 Piramal Corporation Information
11.9.2 Piramal Description and Business Overview
11.9.3 Piramal Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Piramal Medical Sevoflurane Products Offered
11.9.5 Piramal Related Developments
11.10 Hengrui
11.10.1 Hengrui Corporation Information
11.10.2 Hengrui Description and Business Overview
11.10.3 Hengrui Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Hengrui Medical Sevoflurane Products Offered
11.10.5 Hengrui Related Developments
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Corporation Information
11.1.2 Abbott Laboratories Description and Business Overview
11.1.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Abbott Laboratories Medical Sevoflurane Products Offered
11.1.5 Abbott Laboratories Related Developments
11.12 Hikma
11.12.1 Hikma Corporation Information
11.12.2 Hikma Description and Business Overview
11.12.3 Hikma Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Hikma Products Offered
11.12.5 Hikma Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Medical Sevoflurane Market Estimates and Projections by Region
12.1.1 Global Medical Sevoflurane Sales Forecast by Regions 2021-2026
12.1.2 Global Medical Sevoflurane Revenue Forecast by Regions 2021-2026
12.2 North America Medical Sevoflurane Market Size Forecast (2021-2026)
12.2.1 North America: Medical Sevoflurane Sales Forecast (2021-2026)
12.2.2 North America: Medical Sevoflurane Revenue Forecast (2021-2026)
12.2.3 North America: Medical Sevoflurane Market Size Forecast by Country (2021-2026)
12.3 Europe Medical Sevoflurane Market Size Forecast (2021-2026)
12.3.1 Europe: Medical Sevoflurane Sales Forecast (2021-2026)
12.3.2 Europe: Medical Sevoflurane Revenue Forecast (2021-2026)
12.3.3 Europe: Medical Sevoflurane Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Medical Sevoflurane Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Medical Sevoflurane Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Medical Sevoflurane Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Medical Sevoflurane Market Size Forecast by Region (2021-2026)
12.5 Latin America Medical Sevoflurane Market Size Forecast (2021-2026)
12.5.1 Latin America: Medical Sevoflurane Sales Forecast (2021-2026)
12.5.2 Latin America: Medical Sevoflurane Revenue Forecast (2021-2026)
12.5.3 Latin America: Medical Sevoflurane Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Medical Sevoflurane Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Medical Sevoflurane Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Medical Sevoflurane Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Medical Sevoflurane Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Medical Sevoflurane Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Medical Sevoflurane Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Medical Sevoflurane Market Segments
Table 2. Ranking of Global Top Medical Sevoflurane Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Medical Sevoflurane Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Generic Drug
Table 5. Major Manufacturers of Original Drug
Table 6. Global Medical Sevoflurane Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Medical Sevoflurane Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Medical Sevoflurane Sales by Regions 2015-2020 (K MT)
Table 9. Global Medical Sevoflurane Sales Market Share by Regions (2015-2020)
Table 10. Global Medical Sevoflurane Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Medical Sevoflurane Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global Medical Sevoflurane Sales Share by Manufacturers (2015-2020)
Table 13. Global Medical Sevoflurane Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Medical Sevoflurane by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Medical Sevoflurane as of 2019)
Table 15. Medical Sevoflurane Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Medical Sevoflurane Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Medical Sevoflurane Price (2015-2020) (USD/MT)
Table 18. Medical Sevoflurane Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Medical Sevoflurane Product Type
Table 20. Date of International Manufacturers Enter into Medical Sevoflurane Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Medical Sevoflurane Sales by Type (2015-2020) (K MT)
Table 23. Global Medical Sevoflurane Sales Share by Type (2015-2020)
Table 24. Global Medical Sevoflurane Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Medical Sevoflurane Revenue Share by Type (2015-2020)
Table 26. Medical Sevoflurane Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Medical Sevoflurane Sales by Application (2015-2020) (K MT)
Table 28. Global Medical Sevoflurane Sales Share by Application (2015-2020)
Table 29. North America Medical Sevoflurane Sales by Country (2015-2020) (K MT)
Table 30. North America Medical Sevoflurane Sales Market Share by Country (2015-2020)
Table 31. North America Medical Sevoflurane Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Medical Sevoflurane Revenue Market Share by Country (2015-2020)
Table 33. North America Medical Sevoflurane Sales by Type (2015-2020) (K MT)
Table 34. North America Medical Sevoflurane Sales Market Share by Type (2015-2020)
Table 35. North America Medical Sevoflurane Sales by Application (2015-2020) (K MT)
Table 36. North America Medical Sevoflurane Sales Market Share by Application (2015-2020)
Table 37. Europe Medical Sevoflurane Sales by Country (2015-2020) (K MT)
Table 38. Europe Medical Sevoflurane Sales Market Share by Country (2015-2020)
Table 39. Europe Medical Sevoflurane Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Medical Sevoflurane Revenue Market Share by Country (2015-2020)
Table 41. Europe Medical Sevoflurane Sales by Type (2015-2020) (K MT)
Table 42. Europe Medical Sevoflurane Sales Market Share by Type (2015-2020)
Table 43. Europe Medical Sevoflurane Sales by Application (2015-2020) (K MT)
Table 44. Europe Medical Sevoflurane Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Medical Sevoflurane Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific Medical Sevoflurane Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Medical Sevoflurane Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Medical Sevoflurane Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Medical Sevoflurane Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific Medical Sevoflurane Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Medical Sevoflurane Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific Medical Sevoflurane Sales Market Share by Application (2015-2020)
Table 53. Latin America Medical Sevoflurane Sales by Country (2015-2020) (K MT)
Table 54. Latin America Medical Sevoflurane Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Medical Sevoflurane Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Medical Sevoflurane Revenue Market Share by Country (2015-2020)
Table 57. Latin America Medical Sevoflurane Sales by Type (2015-2020) (K MT)
Table 58. Latin America Medical Sevoflurane Sales Market Share by Type (2015-2020)
Table 59. Latin America Medical Sevoflurane Sales by Application (2015-2020) (K MT)
Table 60. Latin America Medical Sevoflurane Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Medical Sevoflurane Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa Medical Sevoflurane Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Medical Sevoflurane Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Medical Sevoflurane Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Medical Sevoflurane Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa Medical Sevoflurane Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Medical Sevoflurane Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa Medical Sevoflurane Sales Market Share by Application (2015-2020)
Table 69. Abbott Laboratories Corporation Information
Table 70. Abbott Laboratories Description and Major Businesses
Table 71. Abbott Laboratories Medical Sevoflurane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Abbott Laboratories Product
Table 73. Abbott Laboratories Recent Development
Table 74. Maruishi Pharmaceutical Corporation Information
Table 75. Maruishi Pharmaceutical Description and Major Businesses
Table 76. Maruishi Pharmaceutical Medical Sevoflurane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Maruishi Pharmaceutical Product
Table 78. Maruishi Pharmaceutical Recent Development
Table 79. Collins Ltd. Corporation Information
Table 80. Collins Ltd. Description and Major Businesses
Table 81. Collins Ltd. Medical Sevoflurane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Collins Ltd. Product
Table 83. Collins Ltd. Recent Development
Table 84. Mylan Seiyaku Ltd. Corporation Information
Table 85. Mylan Seiyaku Ltd. Description and Major Businesses
Table 86. Mylan Seiyaku Ltd. Medical Sevoflurane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Mylan Seiyaku Ltd. Product
Table 88. Mylan Seiyaku Ltd. Recent Development
Table 89. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Corporation Information
Table 90. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Description and Major Businesses
Table 91. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Medical Sevoflurane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Product
Table 93. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Recent Development
Table 94. Baxter Corporation Information
Table 95. Baxter Description and Major Businesses
Table 96. Baxter Medical Sevoflurane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Baxter Product
Table 98. Baxter Recent Development
Table 99. BOC Healthcare Corporation Information
Table 100. BOC Healthcare Description and Major Businesses
Table 101. BOC Healthcare Medical Sevoflurane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. BOC Healthcare Product
Table 103. BOC Healthcare Recent Development
Table 104. Abbvie Corporation Information
Table 105. Abbvie Description and Major Businesses
Table 106. Abbvie Medical Sevoflurane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Abbvie Product
Table 108. Abbvie Recent Development
Table 109. Piramal Corporation Information
Table 110. Piramal Description and Major Businesses
Table 111. Piramal Medical Sevoflurane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Piramal Product
Table 113. Piramal Recent Development
Table 114. Hengrui Corporation Information
Table 115. Hengrui Description and Major Businesses
Table 116. Hengrui Medical Sevoflurane Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Hengrui Product
Table 118. Hengrui Recent Development
Table 119. Lunan Corporation Information
Table 120. Lunan Description and Major Businesses
Table 121. Lunan Medical Sevoflurane Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Lunan Product
Table 123. Lunan Recent Development
Table 124. Hikma Corporation Information
Table 125. Hikma Description and Major Businesses
Table 126. Hikma Medical Sevoflurane Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 127. Hikma Product
Table 128. Hikma Recent Development
Table 129. Global Medical Sevoflurane Sales Forecast by Regions (2021-2026) (K MT)
Table 130. Global Medical Sevoflurane Sales Market Share Forecast by Regions (2021-2026)
Table 131. Global Medical Sevoflurane Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 132. Global Medical Sevoflurane Revenue Market Share Forecast by Regions (2021-2026)
Table 133. North America: Medical Sevoflurane Sales Forecast by Country (2021-2026) (K MT)
Table 134. North America: Medical Sevoflurane Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Europe: Medical Sevoflurane Sales Forecast by Country (2021-2026) (K MT)
Table 136. Europe: Medical Sevoflurane Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Asia Pacific: Medical Sevoflurane Sales Forecast by Region (2021-2026) (K MT)
Table 138. Asia Pacific: Medical Sevoflurane Revenue Forecast by Region (2021-2026) (US$ Million)
Table 139. Latin America: Medical Sevoflurane Sales Forecast by Country (2021-2026) (K MT)
Table 140. Latin America: Medical Sevoflurane Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Middle East and Africa: Medical Sevoflurane Sales Forecast by Country (2021-2026) (K MT)
Table 142. Middle East and Africa: Medical Sevoflurane Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 144. Key Challenges
Table 145. Market Risks
Table 146. Main Points Interviewed from Key Medical Sevoflurane Players
Table 147. Medical Sevoflurane Customers List
Table 148. Medical Sevoflurane Distributors List
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Medical Sevoflurane Product Picture
Figure 2. Global Medical Sevoflurane Sales Market Share by Type in 2020 & 2026
Figure 3. Generic Drug Product Picture
Figure 4. Original Drug Product Picture
Figure 5. Global Medical Sevoflurane Sales Market Share by Application in 2020 & 2026
Figure 6. Children
Figure 7. Adults
Figure 8. Medical Sevoflurane Report Years Considered
Figure 9. Global Medical Sevoflurane Market Size 2015-2026 (US$ Million)
Figure 10. Global Medical Sevoflurane Sales 2015-2026 (K MT)
Figure 11. Global Medical Sevoflurane Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Medical Sevoflurane Sales Market Share by Region (2015-2020)
Figure 13. Global Medical Sevoflurane Sales Market Share by Region in 2019
Figure 14. Global Medical Sevoflurane Revenue Market Share by Region (2015-2020)
Figure 15. Global Medical Sevoflurane Revenue Market Share by Region in 2019
Figure 16. Global Medical Sevoflurane Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Medical Sevoflurane Revenue in 2019
Figure 18. Medical Sevoflurane Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Medical Sevoflurane Sales Market Share by Type (2015-2020)
Figure 20. Global Medical Sevoflurane Sales Market Share by Type in 2019
Figure 21. Global Medical Sevoflurane Revenue Market Share by Type (2015-2020)
Figure 22. Global Medical Sevoflurane Revenue Market Share by Type in 2019
Figure 23. Global Medical Sevoflurane Market Share by Price Range (2015-2020)
Figure 24. Global Medical Sevoflurane Sales Market Share by Application (2015-2020)
Figure 25. Global Medical Sevoflurane Sales Market Share by Application in 2019
Figure 26. Global Medical Sevoflurane Revenue Market Share by Application (2015-2020)
Figure 27. Global Medical Sevoflurane Revenue Market Share by Application in 2019
Figure 28. North America Medical Sevoflurane Sales Growth Rate 2015-2020 (K MT)
Figure 29. North America Medical Sevoflurane Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Medical Sevoflurane Sales Market Share by Country in 2019
Figure 31. North America Medical Sevoflurane Revenue Market Share by Country in 2019
Figure 32. U.S. Medical Sevoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 33. U.S. Medical Sevoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Medical Sevoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 35. Canada Medical Sevoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Medical Sevoflurane Market Share by Type in 2019
Figure 37. North America Medical Sevoflurane Market Share by Application in 2019
Figure 38. Europe Medical Sevoflurane Sales Growth Rate 2015-2020 (K MT)
Figure 39. Europe Medical Sevoflurane Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Medical Sevoflurane Sales Market Share by Country in 2019
Figure 41. Europe Medical Sevoflurane Revenue Market Share by Country in 2019
Figure 42. Germany Medical Sevoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 43. Germany Medical Sevoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Medical Sevoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 45. France Medical Sevoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Medical Sevoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 47. U.K. Medical Sevoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Medical Sevoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 49. Italy Medical Sevoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Medical Sevoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 51. Russia Medical Sevoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Medical Sevoflurane Market Share by Type in 2019
Figure 53. Europe Medical Sevoflurane Market Share by Application in 2019
Figure 54. Asia Pacific Medical Sevoflurane Sales Growth Rate 2015-2020 (K MT)
Figure 55. Asia Pacific Medical Sevoflurane Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Medical Sevoflurane Sales Market Share by Region in 2019
Figure 57. Asia Pacific Medical Sevoflurane Revenue Market Share by Region in 2019
Figure 58. China Medical Sevoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 59. China Medical Sevoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Medical Sevoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 61. Japan Medical Sevoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Medical Sevoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 63. South Korea Medical Sevoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Medical Sevoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 65. India Medical Sevoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Medical Sevoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 67. Australia Medical Sevoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Medical Sevoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 69. Taiwan Medical Sevoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Medical Sevoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 71. Indonesia Medical Sevoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Medical Sevoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 73. Thailand Medical Sevoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Medical Sevoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 75. Malaysia Medical Sevoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Medical Sevoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 77. Philippines Medical Sevoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Medical Sevoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 79. Vietnam Medical Sevoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Medical Sevoflurane Market Share by Type in 2019
Figure 81. Asia Pacific Medical Sevoflurane Market Share by Application in 2019
Figure 82. Latin America Medical Sevoflurane Sales Growth Rate 2015-2020 (K MT)
Figure 83. Latin America Medical Sevoflurane Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Medical Sevoflurane Sales Market Share by Country in 2019
Figure 85. Latin America Medical Sevoflurane Revenue Market Share by Country in 2019
Figure 86. Mexico Medical Sevoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 87. Mexico Medical Sevoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Medical Sevoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 89. Brazil Medical Sevoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Medical Sevoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 91. Argentina Medical Sevoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Medical Sevoflurane Market Share by Type in 2019
Figure 93. Latin America Medical Sevoflurane Market Share by Application in 2019
Figure 94. Middle East and Africa Medical Sevoflurane Sales Growth Rate 2015-2020 (K MT)
Figure 95. Middle East and Africa Medical Sevoflurane Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Medical Sevoflurane Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Medical Sevoflurane Revenue Market Share by Country in 2019
Figure 98. Turkey Medical Sevoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 99. Turkey Medical Sevoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Medical Sevoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 101. Saudi Arabia Medical Sevoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Medical Sevoflurane Sales Growth Rate (2015-2020) (K MT)
Figure 103. U.A.E Medical Sevoflurane Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Medical Sevoflurane Market Share by Type in 2019
Figure 105. Middle East and Africa Medical Sevoflurane Market Share by Application in 2019
Figure 106. North America Medical Sevoflurane Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 107. North America Medical Sevoflurane Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe Medical Sevoflurane Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 109. Europe Medical Sevoflurane Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific Medical Sevoflurane Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. Asia Pacific Medical Sevoflurane Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America Medical Sevoflurane Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Latin America Medical Sevoflurane Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa Medical Sevoflurane Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Middle East and Africa Medical Sevoflurane Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed
セボフルラン・イソフルラン・デスフルランの世界市場（～2026年） Sevoflurane is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether used as an inhalational anaesthetic for induction and maintenance of general anesthesia. After desflurane, it is the volatile anesthetic with the fastest onset and offset. Isoflurane is a general anesthetic. It …- 鎮痛剤デリバリーの世界市場（～2026年） Drug delivery refers to approaches, formulations, technologies and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. Drug delivery is often approached via a drug's chemical formulation, but it may also involve medical devices o…
- 医療用バイオミメティックスの世界市場（～2026年） Market Analysis and Insights: Global Medical Biomimetics Market The global Medical Biomimetics market size is projected to reach US$ 22180 million by 2026, from US$ 21460 million in 2020, at a CAGR of 3.1%% during 2021-2026. Global Medical Biomimetics Scope and Market Size Medical Biomimetics market…
- 薬剤溶出性ビーズの世界市場（～2026年） Drug eluting bead is a therapy for the treatment of hypervascuarized tumours. Drug eluting bead allows for embolization and local release of chemotherapy in the treatment of hepatic malignancy through the intra-arterial delivery of microscopes. Drug eluting bead provides an alternative therapeutic o…
- 医療用射出成形の世界市場（～2026年） Market Analysis and Insights: Global Medical Injection Molding Market The global Medical Injection Molding market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, th…